ADVERTISEMENT
oligomannate alzheimer's disease neurodegeneration microbiome seaweed drug approval china
China Approves Alzheimer’s Treatment that Targets the Microbiome
Oligomannate, derived from a compound in seaweed, suppresses neural inflammation caused by gut bacteria in mice.
China Approves Alzheimer’s Treatment that Targets the Microbiome
China Approves Alzheimer’s Treatment that Targets the Microbiome

Oligomannate, derived from a compound in seaweed, suppresses neural inflammation caused by gut bacteria in mice.

Oligomannate, derived from a compound in seaweed, suppresses neural inflammation caused by gut bacteria in mice.

Alzheimer's Disease, microbiology

3-800x560
Fecal Transplant Restores Youth to Old Mice
Roni Dengler, PhD | Aug 30, 2021 | 3 min read
Microbiota from young mice reversed some aspects of aging and enhanced brain health in aged mice.
Inhaled Antibody Fragments Protect Infected Animals Against COVID-19
Roni Dengler, PhD | Jun 14, 2021 | 2 min read
Tiny but powerful nanobodies may be the innovation that snuffs out the pandemic.
Week in Review: July 21–25
Tracy Vence | Jul 25, 2014 | 3 min read
Blood-based Alzheimer’s diagnostics; CRISPR cuts out HIV; Leishmania and the sand fly microbiome; deconstructing the lionfish science fair debacle
SPRead Your Antibody Capabilities
Carina Storrs | May 1, 2012 | 8 min read
Using surface plasmon resonance to improve antibody detection and characterization: four case studies
ADVERTISEMENT